Motley Fool Wealth Management, LLC Amgen Inc Transaction History

Motley Fool Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $898,233 - $1.08 Million	-5,159 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $3.35 Million - $3.93 Million	-20,115 Reduced 79.59%	5,159 $951,000
Q1 2019 May 07, 2019	BUY	$180.87 - $203.88 $256,654 - $289,305	1,419 Added 5.95%	25,274 $4.8 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $160,203 - $187,008	898 Added 3.91%	23,855 $4.64 Million
Q3 2018 Nov 06, 2018	BUY	$185.29 - $208.89 $57,439 - $64,755	310 Added 1.37%	22,957 $4.76 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $46,826 - $52,595	-282 Reduced 1.23%	22,647 $4.18 Million
Q1 2018 May 04, 2018	BUY	$169.43 - $198.0 $43,204 - $50,490	255 Added 1.12%	22,929 $3.91 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $63,465 - $70,909	376 Added 1.69%	22,674 $3.94 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $3.73 Million - $4.26 Million	22,298	22,298 $4.16 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Motley Fool Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Motley Fool Wealth Management, LLC with notifications on news.